Orally Disintegrating Tablets: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 16, 2008
May 15, 2020
e9db30b4-68fc-445e-9286-7e4573fd1c00
Related Documents
Abuse-Deterrent Opioids-Evaluation and Labeling
Guidance DocumentApril 2, 2015Center for Drug Evaluation and Research
Tablet Scoring:Nomenclature, Labeling, and Data for Evaluation
Guidance DocumentMarch 13, 2013Center for Drug Evaluation and Research
Medication Guides — Adding a Toll-Free Number for Reporting Adverse Events
Guidance DocumentJune 8, 2009Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox